Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry

Clinical Research in Cardiology

Volumn 103, Issue 12, 2014, Pages 1006-1014

  Von Scheidt, W ^a   Zugck, C ^b   Pauschinger, M ^c   Hambrecht, R ^d   Bruder, O ^e   Hartmann, A ^f   Rauchhaus, M ^g   Zahn, R ^h   Brachmann, J ⁱ   Tebbe, U ^j   Neumann, T ^k   Strasser, R H ^l   Bohm M ^m   Stork S ⁿ   Hochadel, M ^o   Heidemann, P ^a   Senges, J ^o  

^a KLINIKUM AUGSBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

^d Gesundheit Nord   (Germany)

^e ELISABETH KRANKENHAUS ESSEN   (Germany)

^f Klinikum St Georg   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^h KLINIKUM LUDWIGSHAFEN   (Germany)

ⁱ KLINIKUM COBURG   (Germany)

^j KLINIKUM LIPPE DETMOLD   (Germany)

^k UNIVERSITY HOSPITAL ESSEN   (Germany)

^l DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^m SAARLAND UNIVERSITY   (Germany)

ⁿ UNIVERSITY OF WÜRZBURG   (Germany)

^o Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

more..

Author keywords

Device therapy; Heart failure; Hospitalization; Registry; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; MINERALOCORTICOID ANTAGONIST;

ABLATION THERAPY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DEVICE THERAPY; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; KIDNEY DYSFUNCTION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; QUALITY OF LIFE; REVASCULARIZATION; SYSTOLIC HEART FAILURE; TERTIARY CARE CENTER; THYROID DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; GERMANY; HEART FAILURE, SYSTOLIC; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REGISTER; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TRENDS;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART FAILURE, SYSTOLIC; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84911808168     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0743-x     Document Type: Article

References (38)

1. McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC-Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. doi:10.1093/eurheartj/ehs104
2. Maggioni AP, Dahlstroem U, Filippatos G et al (2010) EURObservational research programme: The Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 12:1076–1084
3. Maggioni AP, Dahlstroem U, Filippatos G et al (2013) EURObservational research programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15:808–817
4. Cleland JG, Swedberg K, Follath F et al (2003) The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463
5. Komajda M, Follath F, Swedberg K et al (2003) The EuroHeart failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464–474
6. Jonsson A, Edner M, Alehagen U et al (2010) Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail 12:25–31
7. Oliva F, Mortara A, Cacciatore G et al (2012) Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail 14:1208–1217
8. Fonarow GC, Heywood JT, Heidenreich PA et al (2007) Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National registry (ADHERE). Am Heart J 153:1021–1028
9. Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes. Findings from Optimize-HF. Arch Intern Med 168:847–854
10. Yancy CW, Fonarow GC, Albert NM et al (2009) Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J 157:754–762
11. Albert NM, Fonarow GC, Yancy CW et al (2010) Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (IMPROVE HF). Am Heart J 159:238–244
12. Tavazzi L, Senni M, Metra M et al (2013) Multicenter prospective observational study on acute and chronic heart failure: one year follow up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 6:473–481
13. Stalhammar J, Stern L, Linder R et al (2012) Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients. J Med Econ 15:938–946
14. Lund LH, Svennblad B, Melhus H et al (2013) Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study. Circ Heart Fail 6:174–183
15. Choi DJ, Han S, Jeon ES et al (2011) Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean heart failure registry. Korean Circ J 41:363–371
16. Youn YJ, Yoo BS, Lee JW et al (2012) Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. Circ J 76:1151–1158
17. Parenica J, Spinar J, Vitovec J et al (2013) Long-term survival following acute heart failure: the Acute Heart Failure Database Main registry (AHEAD Main). Eur J Intern Med 24:151–160
18. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M et al (2013) Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure—a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). J Cardiol 62:95–101
19. Sato N, Kajimoto K, Keida T et al (2013) Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 77:944–951
20. Waldum B, Westheim AS, Sandvik L et al (2012) Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry. J Am Coll Cardiol 59:371–378
21. Fruhwald FM, Ulmer H, Pacher R et al (2011) Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry. Wien Klin Wochenschr 123:378–383
22. Fonarow GC, Abraham WT, Albert NM et al (2008) Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from organized program to initiate lifesaving treatment in hospitalized patients with heart failure). Am J Cardiol 102:1524–1529
23. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO (2013) Rehospitalization for heart failure. Problems and perspectives. J Am Coll Cardiol 61:391–403
24. Kociol RD, Peterson ED, Hammill BG et al (2012) National survey of hospital strategies to reduce heart failure readmissions: findings from the Get with the Guidelines-Heart Failure registry. Circ Heart Fail 5:680–687
25. Fonarow GC (2011) Improving quality of care and outcomes for heart failure. Circ J 75:1783–1790
26. Chen J, Dharmarajan K, Wang Y et al (2013) National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 61:1078–1088
27. Lechat P, Cibis-II Investigators (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 353:9–13
28. Fagerberg B, Merit-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001–2007
29. Pitt B, Zannad F, Remme W et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717
30. Packer M, Coats AJS, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658
31. Pitt B, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321
32. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
33. Swedberg K, Komajda M, Boehm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 376:875–885
34. Lenzen MJ, Boersma E, Scholte op Reimer WJM et al (2005) Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 26:2706–2713
35. Lee DS, Ghosh N, Floras JS et al (2009) Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure. Circ Heart Fail 6:616–623
36. Boehm M, Swedberg K, Komajda M et al (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial. Lancet 376:886–894
37. Frankenstein L, Katus HA, Grundtvig M et al. (2013) Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study. Eur J Clin Pharmacol [Epub]
38. Suarez J, Piccini JP, Liang L et al (2012) International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation. Am Heart J 163:804–811